RecruitingNCT07632859

Diagnostic Accuracy of GPT-4o and Claude 4.6 Sonnet in Turkish ED Anamnesis Notes

Diagnostic Accuracy of Large Language Models From Emergency Department Anamnesis Notes: A Comparison of GPT-4o and Claude 4.6 Sonnet With Emergency Medicine Specialists


Sponsor

Marmara University Pendik Training and Research Hospital

Enrollment

600 participants

Start Date

Jun 1, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This retrospective diagnostic accuracy study evaluates the ability of two large language models (LLMs) - GPT-4o (gpt-4o-2024-11-20; OpenAI) and Claude 4.6 Sonnet (claude-sonnet-4-6; Anthropic) - to generate correct diagnoses from anonymized Turkish-language emergency department (ED) anamnesis notes, and compares their performance with the diagnosis entered by the treating emergency physician. A consensus gold standard is established by three independent board-certified emergency medicine specialists who blindly review each note and vote on the primary diagnosis using ICD-10 three-character codes; the majority vote (at least 2 of 3 specialists agreeing) constitutes the reference standard. Both LLMs are evaluated using a standardized zero-shot direct prompting strategy (temperature=0, stateless API sessions). The primary outcome is diagnostic accuracy (proportion of ICD-10 chapter-level matches) and Cohen's kappa for each LLM against the gold standard. Secondary outcomes include top-3 accuracy, treating physician accuracy, inter-model agreement, and subgroup analyses by ESI triage level and ICD-10 chapter. Inter-rater reliability among the three specialists is quantified using Fleiss' kappa. Analyses are performed in Jamovi. This study represents the first evaluation of LLM diagnostic accuracy using Turkish-language clinical notes and the first to benchmark LLM performance against an independent three-specialist majority-vote gold standard rather than against the treating physician's own diagnosis.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with artificial intelligence (ai) in diagnosis, diagnostic errors, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Marmara University Pendik Training and Research Hospital

Istanbul, Istanbul, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07632859


Related Trials